Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - VACCINOGEN INC | Financial_Report.xls |
| EX-23 - EXHIBIT 23 - VACCINOGEN INC | v407000_ex23.htm |
| EX-21 - EXHIBIT 21 - VACCINOGEN INC | v407000_ex21.htm |
| EX-31.1 - EXHIBIT 31.1 - VACCINOGEN INC | v407000_ex31-1.htm |
| 10-K - 10-K - VACCINOGEN INC | v407000_10k.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Vaccinogen, Inc. (“Vaccinogen”) on Form 10-K for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission on April 15, 2015 (the “Report”), Andrew L. Tussing, President, Chief Executive Officer and acting Chief Financial Officer of Vaccinogen, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vaccinogen.
Date: April 15, 2015
| By: | /s/ Andrew L. Tussing | |
| Name: | Andrew L. Tussing | |
| Title: |
President, Chief Executive Officer and acting Chief Financial Officer (Principal Executive Officer and Principal Financial Officer) |